Abbott Laboratories ABT

101.29 0.22 0.22% as of 25 Sep
Market cap
$174.8B
P/E
32.8×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio
33.68 14.79 33.70 28.03 35.72 43.80 42.17 54.38 226.12 41.99
P/S ratio
4.92 4.69 4.77 4.40 5.80 5.61 4.81 4.16 3.73 2.77
P/FCF ratio
29.50 30.99 37.78 24.61 28.89 33.91 34.14 25.92 23.07 27.70
P/Operating CF
65.80 68.62 62.92 82.59 81.45 51.11 63.56 72.04 62.37 49.30
P/B ratio
4.13 4.11 4.92 5.21 6.93 5.88 4.91 4.14 3.29 2.78
Price to Tangible BV
9.40 10.85 30.18 52.60 4,626.18 0.00 0.00 0.00 0.00 6.79
EV/Sales
5.01 4.84 4.95 4.55 5.98 5.94 5.25 4.66 4.40 2.86
EV/EBITDA
19.89 20.21 20.42 17.09 21.53 23.67 22.18 20.47 21.90 13.11
EV/Operating CF
23.22 23.72 27.34 20.74 24.46 26.01 27.28 22.61 21.62 18.60
EV/FCF
30.04 31.96 39.24 25.46 29.79 35.90 37.21 29.03 27.15 28.62
Quick Ratio
1.02 1.05 1.00 1.06 1.28 1.14 0.88 1.03 1.67 3.31
Current Ratio
1.58 1.67 1.64 1.63 1.85 1.72 1.44 1.62 2.26 4.02
Net Debt/EBITDA
0.36 0.61 0.76 0.57 0.65 1.31 1.83 2.20 3.29 0.42
Debt/Assets
14.91% 17.35% 20.05% 22.53% 24.00% 25.55% 26.42% 28.83% 36.35% 39.27%
Debt/Equity
0.25 0.29 0.38 0.45 0.50 0.56 0.57 0.63 0.89 1.00
Asset Turnover
0.53 0.54 0.54 0.58 0.58 0.49 0.47 0.43 0.42 0.44
Operating CF/Net income
1.47 0.64 1.27 1.38 1.49 1.76 1.66 2.66 11.68 2.29
Capex/Depreciation
(0.70) (0.69) (0.68) (0.54) (0.53) (0.65) (0.54) (0.42) (0.29) (0.74)
Interest Coverage
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
12.96% 30.91% 15.11% 19.01% 20.49% 13.98% 11.89% 7.66% 1.84% 6.66%
ROA
7.76% 17.33% 7.75% 9.27% 9.57% 6.40% 5.46% 3.30% 0.74% 2.98%
ROIC
8.87% 7.89% 8.76% 12.01% 12.02% 7.54% 6.28% 4.96% 1.99% 8.36%
Return on Tangible Assets
30.61% 66.49% 30.15% 36.69% 35.19% 25.59% 28.71% 17.96% 2.53% 5.42%
Average Days of Receivables
65.29 60.25 59.74 51.99 54.97 67.65 62.07 61.86 69.95 56.85
Research and Development Expense of Revenue
6.64% 6.78% 6.83% 6.62% 6.37% 6.99% 7.65% 7.52% 8.25% 6.94%
Selling, General and Administrative Expense of Revenue
27.82% 27.88% 27.30% 25.77% 26.29% 28.02% 30.61% 31.87% 33.52% 32.30%
Intangible Assets out of Total Assets
0.34 0.37 0.44 0.45 0.48 0.53 0.59 0.63 0.60 0.23
Share Based Compensation of Revenue
1.50% 1.60% 1.61% 1.57% 1.49% 1.58% 1.63% 1.56% 1.48% 1.49%
Graham Net Nets
(0.04) (0.05) (0.06) (0.06) (0.06) (0.10) (0.14) (0.17) (0.24) (0.09)
Graham Number
50.37 68.84 40.46 43.04 42.42 32.36 28.65 22.87 10.23 17.13
Earnings Yield
2.97% 6.76% 2.97% 3.57% 2.80% 2.28% 2.37% 1.84% 0.44% 2.38%
Free Cash Flow Yield
3.39% 3.23% 2.65% 4.06% 3.46% 2.95% 2.93% 3.86% 4.34% 3.61%
Revenue per Share
25.46 24.11 23.05 24.90 24.27 19.52 18.05 17.39 15.74 14.12
Operating CF per Share
5.49 4.92 4.17 5.47 5.93 4.46 3.47 3.58 3.20 2.17
Capex per Share
(1.25) (1.27) (1.27) (1.01) (1.06) (1.23) (0.93) (0.79) (0.65) (0.76)
Free Cash Flow per Share
4.25 3.65 2.91 4.45 4.87 3.23 2.54 2.79 2.55 1.41
Cash per Share
5.13 4.58 4.18 5.80 5.77 4.03 2.34 2.32 5.52 12.71
Shareholders Equity per Share
30.31 27.53 22.31 21.05 20.30 18.61 17.70 17.48 17.87 14.03
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
30.31 27.53 22.31 21.05 20.30 18.61 17.70 17.48 17.87 14.03
Free Cash Flow
7,395.00 6,351.00 5,059.00 7,804.00 8,648.00 5,724.00 4,498.00 4,906.00 4,435.00 2,082.00
Working Capital
9,500.00 9,499.00 8,829.00 9,735.00 11,134.00 8,534.00 4,804.00 5,620.00 11,235.00 20,116.00
Capital Expenditures
(2,171.00) (2,207.00) (2,202.00) (1,777.00) (1,885.00) (2,177.00) (1,638.00) (1,394.00) (1,135.00) (1,121.00)
Net Current Asset Value
(7,946.00) (9,857.00) (11,717.00) (12,309.00) (14,933.00) (19,104.00) (20,919.00) (21,819.00) (25,005.00) (5,173.00)
EV/EBIT
27.58 29.74 30.65 23.76 30.58 38.36 36.93 39.02 76.98 19.69
Capex to Sales
0.05 0.05 0.05 0.04 0.04 0.06 0.05 0.05 0.04 0.05
Net Profit Margin
14.72% 31.95% 14.27% 15.88% 16.42% 12.99% 11.56% 7.74% 1.74% 6.71%
Price to Operating Income
27.09 28.84 29.51 22.97 29.65 36.24 33.89 34.84 65.41 19.06
Other line items
Depreciation/Fixed assets
0.26 0.30 0.32 0.36 0.39 0.37 0.38 0.44 0.52 0.27
Cash ROIC
(3.01%) (3.00%) (4.76%) 0.66% 2.45% (1.92%) (3.56%) (2.33%) (2.98%) (4.16%)
Accounts Receivable Turnover
5.97 6.22 6.28 6.87 6.68 5.85 6.02 5.86 6.45 6.26
Accounts Payable Turnover
4.58 4.41 4.04 4.25 4.44 4.17 4.25 4.73 6.93 8.05
Inventory Turnover
3.05 2.93 2.82 3.38 3.65 3.22 3.26 3.44 4.11 3.61
Average Days of Payables
80.11 81.85 87.21 87.85 86.80 96.00 89.71 85.46 70.65 47.28
Days of Inventory on Hand
122.58 120.86 133.41 117.71 101.54 121.93 119.06 109.05 105.92 97.69
Average Receivables
7,427.00 6,745.00 6,391.50 6,352.50 6,450.50 5,919.50 5,303.50 5,215.50 4,248.50 3,333.00
Average Payables
4,217.50 4,245.00 4,451.00 4,507.50 4,177.00 3,599.00 3,113.50 2,688.50 1,790.00 1,129.50
Average Inventory
6,341.00 6,382.00 6,371.50 5,665.00 5,084.50 4,664.00 4,056.00 3,698.50 3,017.50 2,516.50
Average Assets
84,063.50 77,314.00 73,826.00 74,817.00 73,872.00 70,217.50 67,530.00 71,711.50 64,458.00 46,956.50
Average Common Equity
50,336.00 43,364.00 37,866.00 36,464.50 34,513.50 32,152.00 31,011.50 30,910.00 25,907.50 21,021.50

Fold the line items

Columns are period end dates